Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

Healthcare Biotechnology
"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > IMO, a salvage operation....
View:
Post by pfm1998 on Sep 02, 2015 11:49pm

IMO, a salvage operation....

..ENDO returned product due to poor enrollment and missed primary end-point....so why is share price not higher if simply going for market approval after discussions with FDA....what is mgmt not saying?
Comment by DryBones on Sep 03, 2015 12:36am
re Endo.  You are wrong on all points.  Endo designed a trial based on their on Valstar which was ineffective.  This was not the trial they had agreed originally agreed to do.  They could not enroll patients because everyone knew they could get Valstar not MCNA.  So the endpoint was not missed, it never happened in the first place.  Endo gave back the rights, red ...more  
Comment by simouuun on Sep 03, 2015 5:22am
Wasn't the study planed with Mitomyn C? A treatment not approved for the type of the relevant population? 
Comment by ragingbull1327 on Sep 03, 2015 6:34am
Lol.   Valstar.   Endo sucks
Comment by ragingbull1327 on Sep 03, 2015 8:22am
Actually, not fair.  Endo doesn't suck.   They're just not as good as they think they are.   Blackberry however, sucks.  
Comment by DryBones on Sep 03, 2015 11:13am
yeah my memeory sucks too.  
TELESTA THERAPEUTICS INC
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities